Mylan’s EpiPen Profit 60% Higher Than Told to Congress

Mylan says that the $100 profit per two-pack of its EpiPen injectors presented by CEO Heather Bresch to Congress last week is actually 60% higher.

[dpp]
EOF

Vote on this story -->>>


Comments are closed.

this is a single

THE MIAMI METROPOLIS -your source for news, music, sports, movies, restaurants, reviews, weather, travel, arts, tech and events in Miami